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The body plan of the mammalian embryo is shaped through the process of gastrulation, 
an early developmental event that transforms an isotropic group of cells into an 2 
ensemble of tissues ordered with reference to three orthogonal axes1. While model 
organisms have provided much insight into this process, we know very little about 4 
gastrulation in humans due to the difficulty of obtaining embryos at such early stages 
of development, as well as to the ethical and technical restrictions that limit the 6 
feasibility of observing gastrulation ex vivo2. Here we show that human embryonic stem 
cells can be used to generate gastruloids: three dimensional multicellular aggregates 8 
that differentiate to derivatives of the three germ layers organised spatiotemporally, 
without additional extra-embryonic tissues. Human gastruloids undergo elongation 10 
along an anteroposterior axis and, using spatial transcriptomics, we show that they 
exhibit patterned gene expression. This includes a somitogenesis signature that 12 
suggests that 72 hour human gastruloids exhibit features of Carnegie Stage 9 
embryos3. Our study represents a new, experimentally tractable model system to reveal 14 
and probe human-specific regulatory processes occurring during axial organisation in 
early development.  16 
 
The body plan of mammalian embryos emerges through interactions of sequential cell fate 18 
decisions and morphogenetic events, which have hitherto been difficult to observe in humans. 
Human Embryonic Stem Cells (hESCs)4 have opened up opportunities for studying early fate 20 
decisions, and have hinted at the existence of regulatory mechanisms specific to humans5,6. 
But, in contrast to the embryo, where proportionate populations interact with one another to 22 
generate tissues and organs, differentiation in adherent culture is heterogeneous and favours 
a limited number of cell types7. Seeding hESCs on micropatterned surfaces yields coordinated 24 
patterns of gene expression, but without the axial organization characteristic of embryos8. 
However, when mouse ESCs are aggregated in suspension under defined conditions, they 26 
generate ‘gastruloids’: a three-dimensional, in vitro model of mammalian development, which 
exhibits an embryo-like spatiotemporal organization of gene expression9,10. We hypothesised 28 
that similar human gastruloids could be derived from hESCs.  
 30 
Generation of human gastruloids 
When hESCs in 2D culture were treated with Chiron, a Wnt agonist, for one day before 32 
seeding defined numbers in low-adherence plates in the presence of Chiron, they formed 
compact, spherical aggregates within a few hours (Fig. 1a, Extended Data Fig. 1a-c). These 34 
aggregates progressively broke symmetry and formed elongated structures, with maximal 
elongation at 72-96h (Fig. 1a-d). On average, ~66% of aggregates from each experiment 36 
displayed an elongated morphology at 72h. Although some of the structures remained 
 3 
elongated until 96h, the majority tended to curl or retract after 72h (Fig. 1e and Extended Data 38 
Fig. 1d; see Methods for details of classification). Different cell lines required different 
concentrations of Chiron stimulation (Extended Data Fig. 1e).  40 
 
Before aggregation, pre-treated hESCs were found to express pluripotency markers but with 42 
increased expression of mesendodermal marker genes including BRA, MIXL1, EOMES 
(Extended Data Fig. 2a; Supplementary Table 1) and membrane localised CDH2 (N-Cadherin) 44 
(Extended Data Fig. 2b-d). These results suggest that following Chiron pre-treatment, hESCs 
become partially primed towards a primitive streak-like state, in agreement with observations 46 
that Wnt signalling induces mesodermal differentiation of hESCs7,11. 
 48 
Axial organisation of gene expression 
Polarised expression of BRA protein was detectable as early as 24h (Extended Data Fig. 3a) 50 
overlapping a SOX2 expressing domain which, by 96h, had resolved into distinct BRA+ and 
SOX2+ expressing regions (Fig. 1g). All cells exhibited CDH2 expression with higher levels in 52 
the posterior BRA+ and SOX2+ domain (Fig. 1g; Extended Data Fig. 3b). A group of GATA6 
expressing cells were localized at one end, opposite to cells expressing CDX2 (Fig. 1g) and 54 
this pattern was refined as the aggregates underwent elongation (Extended Data Fig. 3c-f; 
see Methods for details of classification). The polarisation of GATA6 was confirmed using live-56 
imaging of a S4-GATA6 reporter line12 and occurred as early as 24h (Supplementary Video 1 
and Extended Data Fig. 3g). The CDX2 expressing region also contained BRA expressing 58 
cells (Fig. 1g), suggesting a correspondence to posterior embryonic identity, since co-
expression of these genes is restricted to the tailbud of mammalian embryos.  60 
 
To ascertain whether human gastruloids were capable of generating derivatives of the three 62 
germ layers, we made use of a reporter line (RUES2-GLR13) to identify progenitors for the 
mesoderm (BRA), endoderm (SOX17) and neuroectoderm (SOX2) (Fig. 2a). Time lapse video 64 
of RUES2-GLR during aggregation (Supplementary Video 2) and elongation (Supplementary 
Video 3) allowed us to follow the process of symmetry-breaking and segregation of germ layer 66 
progenitors. Initially, all cells express SOX2 (Fig. 2b) before individual SOX17+ cells emerge 
throughout the aggregate and SOX2 expression becomes confined to one end of the 68 
aggregates (Fig. 2c). Between 24-48h, BRA expression, initially low and ubiquitous, increases 
and becomes localised to the SOX2 expressing region of the aggregate. By 72h, aggregates 70 
expressed BRA at the distal end, with neighbouring SOX17 and SOX2 expressing domains 
(Fig. 2d). The profiles of these fluorescent reporter genes were comparable among individual 72 
gastruloids when aligned along their AP axis (Fig. 2e). 
 4 
The Chiron pre-treatment was absolutely necessary for elongation and patterned gene 74 
expression (Fig. 1d and Extended Data Fig. 1a-b). However, in our experiments, Wnt3a pre-
treatment was unable to substitute for Chiron, as evidenced by a lack of elongation and 76 
absence of BRA expression (Extended Data Fig. 4a), suggesting differential effects between 
Chiron and Wnt3a in hESCs14. We also found that BMP4, which is used to trigger patterned 78 
gene expression in micropatterns8, was unable to substitute for Chiron and led to small, 
spherical aggregates with no discernible patterning (Extended Data Fig. 4b). These 80 
observations highlight differences in the cellular response to signals, perhaps associated with 
the dimensionality of the system. They also suggest that the formation of human gastruloids 82 
is highly dependent on the signalling exposure of the initial cell population. 
 84 
To investigate further the dependence of human gastruloid formation on signalling, we applied 
small molecule inhibitors of BMP, Wnt and Nodal signalling during pre-treatment. When 86 
RUES2-GLR cells were exposed to routine levels of Chiron in the presence of BMP 
(LDN193189) or Wnt (XAV-939) inhibition, hESCs were not able to form patterned aggregates 88 
or to elongate (Extended Data Fig. 4c). Likewise, inhibition of Nodal signalling (SB431542; 
“SB43”) led to ovoid aggregates that co-express both SOX2 and BRA (Extended Data Fig. 90 
4d), though increasing the concentration of Chiron during aggregation elevated BRA 
expression and led to robust elongations, with co-expression of BRA and SOX2 at the 92 
posterior pole (Extended Data Fig. 4d). These results suggest that a balance between the 
levels of Nodal and Wnt/ß-catenin signalling plays a role in establishing fate decisions and 94 
promoting elongation in human gastruloids. 
 96 
Having observed this signal-dependence during human gastruloid formation, we examined 
the effect of sustained gastruloid culture with Retinoic Acid (RA), known to disrupt axial 98 
patterning and cause congenital malformations15. RA treated gastruloids were typically 
rounded and exhibited high SOX2 expression, with a strong reduction in BRA expression, 100 
although they had separate domains of CDX2 and GATA6 (Extended Data Fig. 4e-f). This 
suggests that certain elements of axial patterning and organisation, particularly elongation, 102 
were adversely affected by RA application in the human gastruloids. 
 104 
These results support the notion that the signalling environment, before and during gastruloid 






A transcriptional body plan in human gastruloids 
To explore the transcriptional complexity of human gastruloids, we applied tomo-sequencing 112 
(tomo-seq)16 to 72h Chiron pre-treated RUES2-GLR gastruloids (Methods). Two replicates 
were embedded and sectioned along their AP axis, before RNA-seq processing each of the 114 
sections (Fig. 3a-b and Extended Data Fig. 5a; Methods).  
 116 
We found 1,023 genes that were reproducible between the two replicates (Methods), 
organised into 22 main classes of expression patterns with representatives of all three germ 118 
layers (Fig. 3c-e and Extended Data Fig. 5b-c, Supplementary Data 1-2). Most notably, six 
clusters, localised to the posterior-most region of the gastruloid (Clusters 0-5), contained 120 
genes whose homologues are localized in the tailbud of mouse embryos, including BRA, 
CDX2, and CYP26A1. At the opposing end, we observed 9 clusters (Clusters 6-14), containing 122 
genes associated with cardiac and anterior endoderm development in the mouse embryo, 
including KDR, MEIS1/2, PBX1, TWIST1, ISL1, IRX1/2/3 and PRDM1 (Supplementary Data 124 
3; Fig. 3c, d). Cluster 21 was strongly enriched for genes involved in somitogenesis and the 
Notch signalling pathway.  126 
 
We did not find evidence for the expression of genes associated with the development of 128 
anterior neural structures (Extended Data Fig. 6a) but observed expression of many 
paralogues from the 4 HOX clusters (Extended Data Fig. 6b). In mouse embryos, Hox genes 130 
are known to be sequentially expressed along the anteroposterior axis. In human gastruloids,  
HOX genes exhibit variable expression domains along the length of the gastruloid AP axis, 132 
but display a somewhat broader domain of paralogues 1-5, and more posterior-biased 
distribution of groups 6-8. Paralogues 9-13 were variably or lowly/not expressed (Fig. 3f and 134 
Extended Data Fig. 6b). Some posterior genes also exhibited expression in the anterior part 
of the gastruloid (e.g. HOXA9-10 and HOXC9-10; Fig. 3f). Currently, in the absence of an 136 
embryonic reference it is not possible to discern whether this localization reflects an early 
phase in the regulation of HOX gene expression, a species difference or a feature of this 138 
model system.  
 140 
These global patterns of gene expression raised the question of whether this organization 
reflects elements of a body plan, the blueprint for the organism. This possibility is supported 142 
by the organization of a posterior domain of gene expression in the human gastruloids (Fig. 
4a-b), where we observed a node-like transcriptional domain (Fig. 4c-d, Extended Data Fig. 144 
6c)17. At the anterior end, we observed the polarisation of genes associated with cardiac 




Signalling and Pattern Organisation 
One of the mechanisms by which gastruloids might establish or maintain patterning along their 150 
AP axis includes the organization of signalling components along their length. Assessing this 
in the tomo-seq data, we observed a number of Wnt ligands preferentially expressed at the 152 
posterior-end (WNT5A, WNT3A, WNT5B, LEF1 and WNT3) and some BMP ligands anteriorly 
(BMP2, BMP4 and BMP5; Extended Data Fig. 6d). Using a BMP/SMAD1 reporter line20, we 154 
observed increased nuclear SMAD1-RFP at the anterior end (Extended Data Fig. 6e-f). 
Anterior BMP signalling localisation is consistent with its function in cardiac development of 156 
the mammalian embryo. At the posterior end we observed expression of WNT3a and LEF1, 
indicating Wnt signalling within the posterior region (Extended Data Fig. 6g-h). Additionally, 158 
we observed a peak of Nodal signalling components and targets, including NODAL, LEFTY1/2 
and CER1, within the posterior region of human gastruloids (Extended Data Fig. 6i). This is 160 
consistent with a known role of Wnt and Nodal signalling in the mammalian tailbud, and 
together suggests that human gastruloids might utilise signalling gradients along their AP axis 162 
to establish patterning. 
 164 
In mouse embryos, Nodal signalling plays an early role in establishing different fates along the 
AP axis, before becoming localized to the posterior pole and the node21,22. Having observed 166 
that suppression of Nodal signalling during pre-treatment could still lead to robust elongation 
of human gastruloids (Extended Data Fig. 7a-b and Extended Data Fig. 4d), we wanted to 168 
examine the organization of gene expression in these gastruloids closely. Gastruloids pre-
treated with Chiron and SB43 displayed a larger, well-defined SOX2 domain at their posterior 170 
end, diffuse expression of BRA that approximated an anteroposterior gradient, and an 
absence of detectable SOX17 expression (Extended Data Fig. 7b-d; Supplementary Table 2). 172 
Comparative analysis between 120h Chiron and SB43 pre-treated gastruloids and those 
without Nodal-signalling inhibition (Extended Data Fig. 7d-g and Extended Data Fig. 8a-c, 174 
Supplementary Data 4-5 and Methods) showed that although 301 genes were reproducibly 
localised in both conditions, SB43 treatment led to the acquisition of 944 genes with novel 176 
spatial localisation, and the loss of reproducible localisation of 509 genes (Extended Data Fig. 
7e; Supplementary Data 5). Additionally, 564 genes (33%) were differentially expressed 178 
between the two treatments (Extended Data Fig. 7f and Supplementary Data 6). One cluster 
of genes lost on SB43 pre-treatment (Cluster 4; Extended Data Fig. 7g) included genes known 180 
to be involved in Nodal signalling and many associated with the node in mammalian embryos 
(Supplementary Data 5), consistent with a loss of Nodal activity. We also noticed a decrease 182 
in expression of genes associated with definitive endoderm (SHH, LHX1, CER1, FOXA3, 
SORCS2, FOXA2) consistent with a role of Nodal in the specification of this germ layer in 184 
 7 
mouse embryos21, and a loss of genes associated with cardiac development (TBX5, GATA6, 
LBX1, NKX2.5) likely to be a consequence of the loss of induction from the endoderm23 186 
(Extended Data Fig. 8d, e and Supplementary Data 7). 
 188 
Together, these observations indicate that the spatial organization of signalling molecules, 
and their activity in human gastruloids, mirror those of mammalian embryos. 190 
 
Comparative spatial transcriptomics 192 
 
The high degree of organization in gene expression that we observed in human gastruloids 194 
prompted us to explore the correspondence of these patterns with other developmental 
models. To do this, we focused on mouse gastruloids as an equivalent model system9,10. The 196 
comparison of tomo-seq datasets showed a high degree of conservation in axial patterning 
(Fig. 4g and Supplementary Data 8). In particular we observed a conserved pattern of 198 
mesodermal differentiation in the axial region of the gastruloids24. There was a posterior-to-
anterior signature for somitogenesis with expression of tailbud genes (BRA, CDX2 and LFNG) 200 
posteriorly, a short domain of MESP1 and MESP2, followed by a more anterior, broader 
domain of MEOX1 and TCF15 expression (Fig. 4h). The overall pattern of gene expression 202 
therefore mirrors the organisation of paraxial mesoderm specification and differentiation in a 
mammalian embryo25, as well as temporal sequences of somitogenesis in hESCs7,26. In 204 
contrast to these conserved patterns, we also noticed genes that were expressed in different 
regions (Clusters 0, 2-3 and 13 for example, Supplementary Data 8) or uniquely expressed 206 
(Extended Data Fig. 9a-e and Supplementary Data 9) in each of the two systems, supporting 





The human gastruloid system that we have introduced represents a first step towards the in 
vitro modelling of the emergence of the human body plan in a 3D context. In this regard, the 214 
axial organization of the somitogenesis program of gene expression that we observed, 
suggests an approximate staging. Examination of images of extant collections of human 216 
embryos3 reveals a major transition between Carnegie Stages (CS) 8 and 9 (corresponding 
to days 17-19 and days 19-21 respectively), associated with the onset of somitogenesis (Fig. 218 
4i); images of CS9 embryos reveal the presence of 1 to 3 somite pairs that are absent in CS8. 
In the human gastruloids, the pattern of gene expression, with a central somitic domain and 220 
posterior presomitic domain of a similar length, leads us to suggests that 72h human 
 8 
gastruloids might serve as a model for some of the features of late CS8 or early CS9 human 222 
development. Since, with the current protocol, the majority of human gastruloids curl or retract 
after 72h, this likely represents a technical limitation, and extension beyond this point will be 224 
subject of future studies. 
 226 
The lack of anterior neural and extraembryonic lineages, characteristic of gastruloids, raises 
important questions about the self-organisation of the mammalian body plan, but also removes 228 
several of the ethical considerations associated with prolonged human embryo culture. The 
tractable nature of human gastruloids should allow the detailed exploration of a variety of 230 
questions associated with early human development and represents an experimental model 
that could prove fruitful in the study of the mechanisms associated with early human 232 
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Fig. 1 | Structure and morphology of human gastruloids. a, Schematic of human gastruloid 234 
protocol. Chi, CHIR99021; ROCKi, ROCK inhibitor; E6, Essential 6 medium. b, Temporal 
morphology. Shown are two representative examples from MasterShef7 (mShef7) cell line. (N 236 
= 3 experiments). Scalebar, 200 µm. c, Estimated number of cells in human gastruloids. Data 
from 2-4 independent biological replicates (Welch two-sided, two-sample t-test; Source Data). 238 
d, Elongation of RUES2-GLR gastruloids (center line, median; whiskers, interquartile range). 
Shown are data from N = 2-4 independent biological replicates (Rep) (Welch two-sided, two-240 
sample t-test; ****, p < 2.2e-16; see Source Data and Methods). e, Proportion of elongated 
RUES2-GLR gastruloids at 72h, as quantified using an automated measure of morphological 242 
elongation (see Methods for details). Shown are N = 7 independent biological replicates (left), 
and the average proportions (right). Representative images of each elongation category can 244 
be seen in Extended Data Fig. 1d. f, Scanning Electron Micrograph (SEM) of RUES2-GLR 
human gastruloids at 72h. Shown are two representative examples, n = 28 gastruloids. Scale 246 
bars; 200 µm. g, Projections of immunofluorescence-labelled RUES2-GLR human gastruloids 
at 72h (top) and 96h (bottom). Insets, individual sections (bounded by dashed lines). Scale 248 
bars; 100 µm. c-e, n, number of gastruloids.  
 
Fig. 2 | Dynamic polarization of cell types associated with three germ layers in human 
gastruloids. a, Schematic of the RUES2-GLR cell line. CDS, Coding Sequence; mCit, 
mCitrine; tdTom, tdTomato; mCer, mCerulean. b, The temporal dynamics of RUES2-GLR 
human gastruloid development. Shown are two representative examples. Colours indicate 
reporter fluorescence as in panel (a). Scale bar; 200 µm. Representative example, from N > 
5 independent experiments. c, Stills from live-imaging of RUES2-GLR human gastruloids. 
Colours as in panel b. Scale bar; 100 µm. Representative example, from 3 independent 
experiments. d, Localization of the three germ layer reporters at 72h. Shown are 3 examples. 
 11 
Representative example, from N > 5 independent experiments. Scalebar, 100 µm. e, 
Quantification of the dynamics of reporters along the anteroposterior axis of elongating 
gastruloids. Thin line, individual gastruloids; thicker line, average of each timepoint. A = 
Anterior, P = Posterior. 
 
Fig. 3 | Transcriptomic anteroposterior organization of human gastruloids. a, Widefield 
imaging of 72h RUES2-GLR derived human gastruloids used for tomo-sequencing. Scale 
bars; 100 µm. mCer, mCerulean; tdTom, tdTomato; mCit, mCitrine. n = 2 gastruloids. b, mRNA 
of the fluorescent reporter transgenes along the anteroposterior (AP) axis. c, Transcriptomic 
analysis of 1,023 significantly reproducible genes along the AP axis of two 72h RUES2-GLR 
derived Chiron pre-treated human gastruloids. Coloured panels (left) show clusters of genes 
with similar expression patterns (see Methods, Supplementary Data 1). Two replicates are 
shown. d, Average AP expression for genes in selected clusters, and corresponding enriched 
Gene Ontology (GO) terms. Shaded ribbon corresponds to the standard deviation of the 
cluster, line to the mean average (Supplementary Data 3). e, Expression of characteristic 
markers of all three germ layers. Selected genes are highlighted (Supplementary Data 2). 
Colour-scale equivalent to that of panel (c). f, Localisation of HOX gene expression along the 
AP axis. White bars indicate lack of paralogue. a-f, n = 2 gastruloids. See Source Data and 
Methods. 
 
Fig. 4 | Comparative elements of early embryogenesis. a, Schematic of the mammalian 
embryo tailbud. b, Heatmaps (upper), and line graphs (lower), showing expression localisation 
of tailbud-associated genes in human gastruloids. Line graphs are displayed as smoothened 
gene expression patterns; grey ribbon, 50% Confidence Interval. One replicate shown, n = 2 
gastruloids; Extended Data Fig. 5c. c, Schematic of the mammalian embryo node region. d, 
AP organization of node-associated genes in human gastruloids. Panel organized as in panel 
c. e, Schematic of the mammalian embryo cardiac mesoderm region. f, AP organization of 
cardiac mesoderm region-associated genes in human gastruloids. Panel organized as in 
panel c. g, Heatmap showing AP expression of 253 orthologous, reproducible genes in mouse 
and human gastruloids (left, average human gastruloid; right, average mouse gastruloid), 20 
μm tomo-seq data. Greyscale numbered bars, clustering based on expression patterns; red 
stars, deviation of expression pattern. n = 2 human gastruloids, 5 mouse gastruloids. h, 
Patterned organization of somitogenesis-related genes in human gastruloids, including 
signaling gradients (upper heatmaps) and genes related to the tailbud and somitic tissue 
(lower linegraphs) for n = 2 gastruloids. i, Illustration of Carnegie Stage (CS) 8 and 9, showing 
gross anatomical features, including somite boundaries. Adapted from Ref32. Yellow bars, 
 12 
somites; magenta bars, developing somites and presomitic mesoderm; green bars, primitive 




Ethical statement 252 
The human gastruloid model introduced in this study does not show any evidence of cell 
types associated with anterior neural fates, which would be required to form brain tissue, nor 254 
do they form extraembryonic tissues, which would be required for implantation or show 
evidence of multiorgan differentiation which would be necessary for integrated organ system 256 
development. Significantly, they lack the morphology of an early human embryo, and therefore 
do not manifest human organismal form. As such, they are non-intact, non-autonomous, and 258 
non-equivalent to in vivo human embryos, and do not have human organismal potential. Our 
research was subject to review and approval from the Human Biology Research Ethics 260 
Committee of the University of Cambridge, in compliance with the ISSCR 2016 guidelines.  
 262 
Human Cell lines 
The cell lines used in this study include the hESC lines: MasterShef727, S4-GATA6-GFP12, 264 
RUES2-GLR13 and RUES2:SMAD1-RFP;H2B-mCitrine20 . All cells were cultured in humidified 
incubators at 37°C and 5% CO2. Human ESCs were cultured routinely in Nutristem hPSC XF 266 
medium (Biological Industries, 05-100-1A) on 0.5 µg/cm2 Vitronectin-coated plates (Gibco, 
A14700). Cells were passaged using 0.5 mM EDTA in PBS-/- (Invitrogen, 15575-038). 268 
 
Culturing human gastruloids 270 
A critical part of the process is the starting state of the cells, which must be in optimal condition 
before beginning. When cells were ~40-60% confluent, adherent cultures were pre-treated in 272 
Nutristem supplemented with CHIR99021 (‘Chiron’; Tocris Biosciences, 4423). We found that 
cells did not form elongated gastruloids when cultured in alternative pluripotency medium, 274 
including mTeSR or Essential8. The optimal concentration of Chiron in this pre-treatment was 
cell line dependent and was determined empirically by titration for each new line. 276 
Concentrations for the lines used in this study are described in the following section. After pre-
treatment for 24 hours, cells were dissociated using 0.5 mM EDTA in PBS-/- (Invitrogen, 15575-278 
038), washed in PBS-/- and reaggregated in basal differentiation medium, Essential 6 (‘E6’; 
ThermoFisher, A15165-01), supplemented with 1:2000 Y-27632 (‘ROCK inhibitor’; Sigma 280 
Aldrich, Y0503) and a cell-line dependent concentration of Chiron. Cell numbers were 
determined using an automated cell counter (Moxi Z Mini, ORFLO Technologies, MXZ002) 282 
and 400-600 cells per 40 µl were added to each well of an ultra-low adherence 96-well plate 
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(CellStar, 650970). For all images shown here, 400 cells per well of a 96-well plate were used 284 
to generate human gastruloids, unless otherwise stated. The cell suspension was centrifuged 
using a benchtop plate centrifuge at 700 rpm for 2 minutes. The following day, 150 µl fresh E6 286 
medium was added to each well. Medium was exchanged for fresh E6 medium daily following 
this timepoint. Detailed instructions for generating human gastruloids can be found in Protocol 288 
Exchange28. 
 290 
Cell line-dependent Chiron pulse 
We found that different human ESC lines required different concentrations of Chiron both 292 
before aggregation and for the first day of aggregation, in order to generate elongating 
gastruloids (Extended Data Fig. 1d). Cell-line dependent Chiron doses used in this study were 294 
as follows: RUES2-GLR, 3.25 µM Chiron pre-treatment, 0.5 µM Chiron aggregation; 
MasterShef7, 5 µM Chiron pre-treatment, 3 µM Chiron aggregation; GATA6-GFP, 3.25 µM 296 
Chiron pre-treatment, 0.5 µM Chiron aggregation; RUES2-SMAD1-RFP;H2B-mCitrine, 5 µM 
Chiron pre-treatment, 3 µM Chiron aggregation. 298 
 
Signal Modulation Experiments 300 
RUES2-GLR cells were pre-treated for 1 day in Nutristem supplemented with 100 ng/ml 
recombinant human Wnt3a (5036-WN-010) or 50 ng/ml BMP4 (314-BP), and aggregated in 302 
E6 and ROCK inhibitor with additional supplementation as shown. Subsequent media 
changes were performed daily with E6 alone. To test the effect of signal modulation on 304 
gastruloid formation, RUES2-GLR cells were pre-treated in Nutristem supplemented with 3.25 
µM Chiron and one of 1 µM LDN193189 (04-0074), 1 µM XAV-939 (04-0046), or 10 µM 306 
SB431542 (1614) before aggregation in E6 with 0.5 µM Chiron and ROCK inhibitor, unless 
otherwise stated. Subsequent media changes were performed daily with E6 alone. For 308 
Retinoic Acid (RA) experiments, RUES2-GLR cells were pre-treated as usual in 3.25 µM 
Chiron for 1 day, before aggregation in E6 supplemented with 0.5 µM Chiron, ROCK inhibitor 310 
and 0.5 µM RA (R2625). Subsequent media changes were performed daily with E6 and 0.5 
µM RA.  312 
 
The SB43 pre-treated gastruloids for tomo-sequencing were made with RUES2-GLR cells 314 
pre-treated in Nutristem with 3.25 µM Chiron and 10 µM SB431542 (1614). They were then 
aggregated in E6 with 3 µM Chiron and ROCK inhibitor. Subsequent media changes were 316 
performed daily with E6 alone. 
 318 
Scanning Electron Microscopy 
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Human gastruloids, made from the RUES2-GLR line at 72h after aggregation, were washed 320 
twice with HEPES buffer and fixed overnight in 3% Glutaraldehyde, 0.05 M sodium cacodylate 
buffer pH 7.4 at 4°C. Samples were washed several times in de-ionised water (DIW) at room 322 
temperature (RT) to remove fixative. Melinex coverslips at 12 mm diameter were covered with 
a large drop of poly-L-lysine solution (Sigma P4707) and incubated for 15 minutes at RT. 324 
Excess solution was drained off and the coverslips were allowed to air-dry at 37oC. The 
gastruloids were transferred to the poly-L-lysine coated coverslips in a drop of DIW and 326 
allowed to adhere for about 30 min at RT whilst ensuring that the gastruloids remained covered 
with DIW. Excess DIW was carefully drained off using a tissue paper and the samples were 328 
immediately plunge-frozen in liquid nitrogen-cooled ethane. After freeze-drying overnight in a 
liquid nitrogen-cooled turbo freeze drier (Quorum Emitech K775X), samples were mounted on 330 
aluminium SEM stubs using sticky carbon pads and sputter coated with 35 nm Au followed by 
15 nm iridium. Samples were viewed in a FEI Verios 460 scanning electron microscope using 332 
an Everhart-Thornley detector in secondary electron mode at 2 keV accelerating voltage and 
25 pA probe current. 334 
 
Immunostaining 336 
Human gastruloids were fixed and immunostained according to the existing methods for 
gastruloid staining29 unless otherwise stated. The antibodies used were: 1:200 Rabbit anti-338 
CDX2 (ThermoScientific, EPR2764Y); 1:200 Goat anti-GATA6 (R&D Systems, AF1700); 
1:200 Rabbit anti-BRACHYURY (AbCam, ab209665); 1:200 Goat anti-SOX2 (R&D Systems, 340 
AF2018); 1:200 Mouse anti-CDH2 (BD Biosciences, BD10920); 1:200 Rat anti-CDH1 (Takara, 
M108), 1:100 Rabbit anti-Wnt3a (ab219412), 1:200 Rabbit anti-LEF1 (ab137872), 1:200 342 
Rabbit anti-FOXA2 (ab108422). All secondary antibodies were all diluted 1:500, and included 
Alexa-Fluor-488, -568 and -647 conjugated antibodies (Invitrogen).  344 
 
Adherent cell staining was done using 1:200 Mouse anti-CDH2 (BD Biosciences, BD10920), 346 
1:200 Rat anti-CDH1 (Takara, M108) and 1:200 Rabbit anti-BRACHYURY (AbCam, 
ab209665) primary antibodies. Quantification was performed using Fiji software on the whole 348 
image (histograms) or using a line ROI through the colony (line graph). 
 350 
In situ Hybridisation 
Human gastruloids were collected at 72h or 96h post aggregation. After rinsing them briefly in 352 
PBS, they were fixed in 4% PFA either overnight or 2h at 4 °C and stored in 100% methanol 
at −20 °C until further used. In situ hybridization was performed on whole mount gastruloids 354 
as described9 with minor modifications. Gastruloids were rehydrated by incubating them for 3-
5min in series of decreasing concentration of methanol (75%, 50%, 25% and 0% respectively) 356 
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in TBST (20mM Tris 137mM NaCl, 2.7mM KCl, 0.1% Tween, pH = 7,4). After washing 
gastruloids in TBST, they were incubated in proteinase K (2.5µg/ml) for 2 mins to make them 358 
permeable to probes and post-fixed in 4% PFA for 20min at room temperature, before washing 
again in TBST. To block non-specific interactions, they were prehybridized at 68°C for 4-5 h. 360 
Hybridization was performed by incubating them in 200ng/ml of specific digoxigenin (DIG)-
labelled RNA probes at 68°C overnight. The probe sequences used can be found in 362 
Supplementary Table 2. The following day, after washing the gastruloids at 68°C, they were 
incubated in blocking solution for 1.5h at solution at room temperature. Gastruloids were then 364 
incubated overnight in anti-DIG antibody coupled to alkaline phosphatase (Sigma) at 1:3,000 
dilution in blocking buffer at 4°C. The next day, they were washed in MABT (100 mM maleic 366 
acid, 150 mM NaCl, 0.1% Tween, pH 7.5) overnight at 4°C. Gastruloids were then washed 3 
times with TBST and 3 times in alkaline phosphatase buffer (0.1 M Tris pH 9.5, 100 mM NaCl, 368 
0.1% Tween) and incubated in BM purple solution (Sigma) either at 4°C or RT until the signal 
was fully developed. Gastruloids were washed in TBST and post fixed in 4% PFA for 20min 370 
at RT. For imaging gastruloids were suspended in CUBIC-R1A tissue clearing reagent30,31. 
 372 
RT-qPCR 
Gene expression was analysed from adherent cells using Trizol (Ambion LifeTechnologies) 374 
according to manufacturer’s instructions. Total RNA was quantified using a NanoDrop 2000C 
(ThermoScientific) and 5 µg was added to a reverse transcription reaction with Superscript III 376 
(Invitrogen) according to manufacturer’s instructions. Resultant cDNA was quantified by qPCR 
with SYBRGreen (Merck) using a liquid handling robot (Qiagility, Qiagen) and analysed on a 378 
RotorGeneQ thermocycler (Qiagen). Primer sequences can be found in Supplementary Table 
1. Concentration of cDNA was estimated using an in-house MAK2 analysis method, as 380 
described in32.  
 382 
Imaging 
Confocal imaging was performed using a LSM700 (Zeiss) on a Zeiss Axiovert 200 M using a 384 
40 EC Plan-NeoFluar 1.3 NA DIC oil-immersion objective. Image capture was performed using 
Zen2010 v6 (Carl Zeiss Microscopy Ltd, Cambridge UK). All samples were fixed and 386 
immunostained prior to imaging. For gastruloids made from the RUES2-GLR reporter line, we 
never observed fluorescent signal of reporter proteins following our fixation protocol, and 388 
therefore used the same antibody design and microscope settings as described. 
 390 
Wide-field imaging was performed using a 37°C incubated chamber supplied with 5% CO2, 
attached to a Zeiss AxioObserver.Z1 (Carl Zeiss, UK) as described in33. All images were 392 
analysed using Fiji software34, and any adjustments are always consistent within a panel. 
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Presented images have been rotated to align their AP axis horizontally where necessary, as 394 
indicated by a dark grey background. 
 396 
Image Analysis: Germ Layer Patterning 
Human gastruloids made using the RUES2-GLR reporter line were specifically analysed for 398 
dynamic reporter expression. An in-house MATLAB script was developed to assess the 
dynamic fluorescent marker expression along the AP axis of human gastruloids. Widefield 400 
images of gastruloids were taken at 24h, 48h and 72h and aligned along their anteroposterior 
axis with reference to fluorescent reporter expression. For each sample, a binary image was 402 
generated in the brightfield channel and used as a mask for all fluorescent channels and the 
major (length) axis was identified. Consequently, for every pixel along the length axis, the sum 404 
of intensity values of the respective channel along the width of the aggregate was divided by 
the width of the gastruloid at that specific point, yielding the normalized fluorescence intensity 406 
along the length of the sample. This process was then repeated for every acquired fluorescent 
channel. Gastruloids used for this analysis were a full set from one experimental batch, and 408 
images were only excluded from the analysis when anteroposterior alignment or binarization 
were unsuccessful. 410 
 
Image Analysis: Elongation quantification 412 
In order to quantify the degree of elongation of human gastruloids, brightfield channel widefield 
images were imported into Fiji34. The length of the longest axis was measured using the line 414 
tool, followed by the length of the perpendicular axis at the mid-point of the longest axis line. 
The ratio of these two values was calculated and plotted by time-point and condition, using R. 416 
Significance was assessed using the Welch Two-Sample t-test. This method was used to 
assess the difference in elongation with and without Chiron pre-treatment, as shown in Fig. 418 
1d. 
 420 
Image Analysis: Morphological quantification 
The estimate of the proportions of gastruloid shapes (spherical, ovoid, elongated-short and 422 
elongated-long) was estimated for multiple independent biological replicates. This was 
performed using an in-house method derived from that previously described (Turner 2017, 424 
doi: 10.1242/dev.150391). Briefly, images were converted into single-channel, 8-bit TIFF files 
using FIJI34. These were then processed using Python 3.6 (Python Software Foundation, 426 
https://www.python.org/) and the Open-CV package35 to apply a Gaussian blur before 
performing Otsu’s thresholding and floodfilling with erosion to assign a mask around the shape 428 
of each gastruloid. The length and width values were calculated using a rotated bounding box 
(minAreaRect), which identifies and measures the orthogonally widest and longest parts of 430 
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the gastruloid. Various additional quantitative features were then extracted from the contours, 
which were further processed using R. The categories of each shape descriptor were defined 432 
as follows: Spherical, Circularity less than or equal to 1.1 or Max Width : Max Length (WL) 
greater than or equal to 0.95; Ovoid, Circularity less than or equal to 1.2 or WL greater than 434 
or equal to 0.9; Elongated – Short, Circularity greater than 1.2 and less than or equal to 1.4 
and WL less than 0.9; Elongated – Long, Circularity less than 1.4 and WL less than 0.9. 436 
Images were quality controlled for empty wells or those with debris that compromised shape 
descriptors, using quantification of area or circularity outliers and confirmed manually by 438 
examination of images. This method was used to assess the reproducibility of human 
gastruloid experiments, as shown in Fig. 1e and Extended Data Fig. 1d. 440 
 
Image Analysis: Estimates of cell number 442 
The number of cells per aggregate was estimated using Imaris software (Bitplane) on confocal 
images stained with Hoechst. Spots were drawn using the internal algorithm, using an 444 
estimated xy size of 6 µm, a quality threshold of 2.5 and background subtraction. Because the 
light penetration only allowed us to image part of the gastruloid we assumed this was on 446 
average half of the gastruloid, and so doubled the resultant nuclei estimate. It is likely that this 
process slightly underestimates the number of nuclei. The quantitative data were 448 
subsequently analysed in R. The fitting of an exponential curve was done using the lm() 
function of log transformed data.  450 
 
Image Analysis: Subcellular localisation of SMAD1-RFP 452 
To quantify the level of active SMAD1 in each cell of the gastruloid, we sought to determine 
the nuclear to cytoplasmic ratio of SMAD1-RFP. To do this, we used Imaris software to identify 454 
nuclear positions by creating a surface using the Hoechst channel. We then used these 
surfaces to create two masks: one where everything inside the nuclear mask was set to zero, 456 
and one where everything outside the nuclear mask was set to zero. This allowed us to 
distinguish the nuclear and cytoplasmic components of the SMAD1-RFP signal. To assign the 458 
cytoplasmic component to each individual cell, we used Imaris to create Spots using the 
Hoechst channel (estimated xy diameter: 5.25 µm). These were then processed using ‘Spots 460 
to Spots Nearest Neighbour Distance’ to create maximal cell areas relative to their neighbours. 
We then used these distance-spots to assess the internal nuclear and cytoplasmic component 462 
of SMAD1-RFP in each cell along the AP axis.  
 464 
The data was subsequently analysed in R, by normalising the mean intensity of the nuclear 
SMAD1-RFP component to the mean intensity of the H2B-mCitrine value, in order to account 466 
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for depth bias. This normalised SMAD1-RFP intensity was then divided by the mean intensity 
of the cytoplasmic SMAD1-RFP, to get the normalised nuclear : cytoplasmic SMAD1-RFP 468 
values. 
 470 
Image Analysis: Axial patterning quantification 
RUES2-GLR gastruloids were fixed at 24, 48 and 72h timepoints, stained for GATA6 and 472 
CDX2, and imaged on a confocal. Maximal projection images were generated using Imaris 
software, and nuclei were identified with Imaris using Hoechst staining (estimated xy size of 6 474 
µm, and quality threshold of 2.5). For each nuclear spot, the mean intensity of GATA6 and 
CDX2 fluorescence was acquired and plotted using R. Axial patterning was determined in Fiji 476 
using the segmented line tool with width 80 and the plotprofile tool. For each gastruloid, the 
AP axis was normalised between 0 and 1, and the fluorescent intensities were also scaled 478 
between 0 and 1 for the minimum and maximum values, in order to aid comparison between 
gastruloids. The Aspect Ratio of these gastruloids was calculated manually in Fiji using the 480 
line tool, where the length of the perpendicular axis at the mid-point of the longest axis line 
was defined as the width. Three categories, with cut-offs of < 2.0, > 2.0 and < 2.4, and > 2.4, 482 
corresponded to the observed longest elongation at 24, 48 and 72 hours, respectively. This 
method was used for quantifying elongation in confocal images, as shown in Extended Data 484 
Fig. 3e-f.  
 486 
Tomo-sequencing and Mapping 
Tomo-sequencing was performed using an updated version of published methods16,36 and 488 
analysed with methods described in van den Brink et. al. (associated manuscript). Briefly, 
gastruloids were sectioned along their AP axis, and the mRNA-content of each section was 490 
extracted using SORT-seq37. Paired end (75 bp) sequencing was performed on the resulting 
RNA-seq libraries using the Illumina Next-Seq sequencing platform. Read 1 contains the 492 
section barcode and the unique molecular identifier (UMI). Read 2 contains the biological 
information. Reads 2 with a valid cell/section barcode were selected and mapped using STAR-494 
2.5.3a with default parameters to the human GRCh38 genome (ENSEMBL version 93), and 
only reads mapping to gene bodies (exons or introns) were used for downstream analysis. 496 
Reads mapping simultaneously to an exon and to an intron were assigned to the exon. 
Mappabilities for the different samples range between 44% and 47%. For each section, the 498 
number of transcripts was obtained as previously described38. We refer to transcripts as 
unique molecules based on UMI correction. 500 
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After mapping, spike-ins, ribosomal, and mitochondrial genes were removed from downstream 502 
analysis, together with KCNQ1OT1, LARS2, and MALAT1, because these genes seem to be 
linked to mapping errors and have been shown to be erroneous in earlier studies. 504 
In each gastruloid, data was then normalized to the median number of unique transcripts per 
slice, and the z-score of each gene was extracted along sections.  506 
 
Gene Expression Data Analysis 508 
The reproducibility of AP expression pattern between different gastruloid replicates was 
scored for each gene using a random background model to calculate the Pearson 510 
correlation coefficient p-value (see ref 39 for further details). The p-value threshold to select 
reproducible genes was set at 0.001. These significantly reproducible genes were then 512 
clustered using a Self-Organising Map (SOM) method, followed by Hierarchical Clustering to 
determine general patterns of gene expression along the AP axis.  514 
 
Average gastruloid profiles were generated using the mean of z-scores along the AP axis. 516 
When the number of sections between replicates was different, values were quadratically 
interpolated to fill spaces using the interp1d function from the package scipy.interpolate 518 
(Python 3.6).  
 520 
Differential gene expression was performed by normalizing the transcripts in each section to 
100,000 for all gastruloids; then pooling all sections of each gastruloid together; and finally 522 
assessing significant differentially expressed genes based on total expression using the 
Binomial test.  524 
 
For smoothened line-graphs of gene expression, the distribution of gene expression along the 526 
sections was plotted using R, and smoothened using the geom_smooth() function (method = 
loess, span = 0.3, level = 0.5) to minimise background variability. For each gene expression 528 
distribution, the confidence interval is therefore shown (at 0.5 Confidence Interval) as a grey 
ribbon.  530 
 
Gene Ontology (GO) term analysis for each hierarchical cluster of the Chiron pre-treated 532 
human gastruloids was performed using ENSEMBL IDs run with the DAVID Annotation tool40 
with the human genome as a background model, focussing on Biological Process terms. 534 
Statistical correction for multiple comparisons was achieved using Benjamini adjustment. 
 536 
Gene Ontology for each hierarchical cluster of the human-to-mouse gastruloid comparison 
was performed using the python package goatools41, which uses Fishers exact test, setting 538 
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the p-value at 0.05. Both the list of reproducible genes in each corresponding condition, or the 
full human transcriptome was set as a background model, focussing on Biological Process 540 
terms. Statistical correction for multiple comparisons was achieved using Bonferroni 
adjustment. 542 
 
Mouse Gastruloid comparison  544 
We compared 72h human gastruloids, which we believe correspond approximately to the 
~CS9 human embryo, with 120h mouse gastruloids which are thought to represent an ~E8.0-546 
E8.5 stage embryo and approximately equivalent developmental stages of both species40. 
These mouse gastruloids were generated from the LfngT2AVenus line42. Full details of this 548 
dataset can be found in ref 39. 
 550 
Gene reproducibility analysis between the replicates of mouse gastruloids (P-value < 0.01) 
and the 2 replicates of human gastruloids (P-value < 0.001) was performed, independently 552 
(as described above). Only genes present in the two separate lists that had human-mouse 
orthologs were used for downstream analysis. The list of human-mouse orthologs was 554 
obtained from Biomart, Ensembl 93. Genes were clustered based on their AP expression 
pattern in both the mouse and the human average gastruloid simultaneously, as described 556 
above. The Pearson correlation coefficient for each gene was calculated between the AP 
expression pattern of two different samples (in z- score units). To assess for significantly 558 
correlated genes, we randomly generated 10,000 expression profiles with the same number 
of sections as in the pair of replicates and determine the correlation value at which less than 560 
100 random profiles have larger correlation values (P-value < 0.01). 
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Extended Data Fig. 1 | Chiron pre-treatment optimisation and Morphological variability. 
a, Aggregation of single RUES2-GLR cells following Chiron pre-treatment, showing either a 
single aggregate (left) or presence of transient ‘satellite’ aggregates (right). These typically 
merge within 10 hours (n = 38 gastruloids from N = 2 experiments). b, Schematic of protocol 
without Chiron pre-treatment, but with aggregation in Chiron (Chi) and ROCK inhibitor 
(ROCKi) medium. c, Gastruloids made from the RUES2-GLR line without Chiron pre-
treatment at 24, 48 and 72h after aggregation. Shown are 3 representative examples for each 
timepoint (n = 415 gastruloids), with all three fluorescent reporters (SOX2-mCitrine, SOX17-
tdTomato and BRA-mCerulean; left) and without SOX2-mCitrine (right). Scalebar; 100 µm. 
Representative example, from N = 5 independent experiments. d, Examples of reporter 
patterning in differential morphology classes, as assessed by automated segmentation 
providing gastruloid outline boundaries (yellow line indicates boundary used for 
quantifications). Three representative gastruloids per category are shown (n = 374 
gastruloids). See methods for details of classification method. Scale bar, 100 µm. 
Representative examples, from N = 7 independent experiments. e, Cell line-dependent 
optimisation of Chiron conditions. Shown are MasterShef7 cell-derived human gastruloids 
(left; two examples shown) or RUES2-GLR cell-derived human gastruloids (right; three 
examples are shown). Scalebars; 100 µm. Red bounding boxes indicate concentrations at 
which gastruloids were deemed to be optimally elongated, and resultant conditions for 
subsequent gastruloid derivation. Representative examples, from N = 3 independent 
experiments. 
 
Extended Data Fig. 2 | Effect of Chiron pre-treatment on human embryonic stem cells.  
a, Gene expression following 24 hours of Chiron pre-treatment (Chi PT) in adherent RUES2-
GLR cells compared to non-pretreated cells (No PT) in Nutristem alone, as assessed by RT-612 
qPCR. Shown are averages from 5 biological replicates; bars, mean average; points, technical 
averages for each experimental replicate. Significance (ns, p > 0.05, *, p < 0.05; **, p < 0.01; 614 
***, p < 0.001; Welch two-sided, two-sample t-test; Source Data and Methods). b, 
Immunostaining of adherent colonies of RUES2-GLR cells for BRACHYURY, E-CADHERIN 616 
and N-CADHERIN (CDH1 and CDH2 respectively) with non-pretreated cells (top) or following 
24h Chiron (Chi) pre-treatment (bottom). Scalebar; 100 µm. Dotted region on colony (top 618 
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panels) shows position of enlarged region (bottom panels). Representative example, from N 
= 2 independent experiments. c, Quantified expression from immunostaining of RUES2-GLR 620 
cells, as shown in panel b. The whole image was used to generate this data. d, Profiles of 
membrane localisation of E- and N-cadherin from immunostaining of RUES2-GLR cell 622 
colonies, as shown in panel b. 
 
Extended Data Fig. 3 | Establishing axial patterning in human gastruloids. a, 
Immunofluorescence imaging of a RUES2-GLR human gastruloid at 24h. Shown are confocal 
sections (top) and mean projection (bottom) of the gastruloid. Scalebar; 100 µm. 
Representative example from n = 12 gastruloids, from N = 2 experiments. b, Human 
gastruloids made from MasterShef7 cell line at 72 hours after aggregation, showing BRA, 
SOX2 and N-Cadherin (CDH2) localisation. Shown are 3 representative examples. Scalebar; 
100 µm. Representative example from n = 13 gastruloids, from N = 3 experiments. c, 
Projection of immunofluorescently labelled RUES2-GLR derived human gastruloids at 24, 48 
and 72h with GATA6 (magenta) and CDX2 (yellow) staining. Shown are 6 representative 
gastruloids at each timepoint. Scalebar, 30 µm; small text, Aspect Ratio. Representative 
examples from n = 63 gastruloids from N = 2 independent experiments. d, Scatterplot of co-
expression of GATA6 and CDX2 per cell, across the three timepoints. Blue points, co-
expression over threshold; Grey points, expression below threshold; Small text, number of 
gastruloids in each plot (n). e, Relative axial expression of GATA6 (magenta) and CDX2 
(yellow) along the AP axis. Small text, number of gastruloids in each plot (n). f, Relative axial 
expression of GATA6 (magenta) and CDX2 (yellow) along the AP axis, as stratified by aspect 
ratio (as determined using a manual axial patterning quantification, see Methods for details). 
Small text, number of gastruloids in each plot (n). Thick lines, mean average; Thin lines, 
individual gastruloids. Representative images of such gastruloid elongation classifications can 
be seen in panel c. g, Progressive polarisation and restriction of GATA6-GFP fluorescence to 
the anterior pole of human gastruloids made from the S4-GATA6-GFP cell line. Scalebar; 100 
µm. Representative example from n = 17 gastruloids. 
 
Extended Data Fig. 4 | Disrupting axial patterning in human gastruloids. a, Aggregates 
following pre-treatment with Wnt3a instead of Chiron for 24h in RUES2-GLR cells. 
Representative examples shown (n = 281 gastruloids). b, Aggregates following pre-treatment 
with BMP4 for 24h in RUES2-GLR cells. Representative examples shown (n = 187 
gastruloids). c, Application of a BMP inhibitor, LDN193189 (LDN; left) or Tankyrase inhibitor, 
XAV-939 (XAV; right) during 24h pre-treatment of RUES2-GLR cells. Representative 
examples shown (n = 85 gastruloids). d, Application of a Nodal signalling inhibitor, SB43 
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(SB43) during 24h pre-treatment of RUES2-GLR cells. a-d, Representative examples from N 
= 3 independent experiments. Dark green bounding box indicates the pre-treatment condition 
in Nutristem, and teal box indicates the aggregation medium composition in E6 and ROCK 
inhibitor. Shown are 2 representative examples from each condition. Scalebar; 100 µm. e, 
Addition of Retinoid Acid (RA, right) or DMSO (left) on RUES2-GLR derived human gastruloids 
for each day of aggregate development. Schematic of protocol (top) and imaging results 
(bottom). See Methods for experimental details. Scale bar; 100 µm. Representative examples 
of n = 159 gastruloids, from N = 4 independent experiments. f, Confocal imaging of axial 
patterning defects in RA-treated 72h RUES2-GLR derived human gastruloids. Scalebar; 100 
µm. Representative examples of n = 25 gastruloids, from N = 3 independent experiments. 
 
Extended Data Fig. 5 | Spatial transcriptomics by tomo-seq identifies clusters of gene 
expression. a, Quantification of number of genes (left) and number of unique transcripts 
(right) detectable in each section along the anterior-posterior (AP) axis of 72h Chiron pre-
treated human gastruloids made from RUES2-GLR cells. Blue bars, sections above the 
threshold used for downstream tomo-seq analysis; Grey bars, sections below the threshold 
(see Methods for details). Two replicates are shown. b, Average expression patterns along 
the AP axis of all genes detected in each cluster. Clusters correspond to those in Fig. 3b and 
Supplementary Data 1. Ribbon indicates standard deviation for the set of genes within each 
cluster, line to the mean average. n = 2 gastruloids. c, Selection of gene traces along the AP 
axis for both gastruloids. Blue and green lines, expression values for replicate 1 and 2 
respectively. 
 
Extended Data Fig. 6 | Transcriptional profiles and anterio-posterior (AP) localisation in 
human gastruloids. a, Normalised expression of anterior neural genes in human gastruloids. 
b, Total expression (log10 transformed) of each HOX gene across all sections of Gastruloid 1 
(upper) and Gastruloid 2 (lower), for all 4 clusters (HOXA, HOXB, HOXC and HOXD). White 
boxes indicate that a gene is not present in the human genome. a-b, n = 2 gastruloids. c, 
Expression of FOXA2 in the posterior end of 72h Chiron pre-treated RUES2-GLR gastruloids. 
Three representative examples are shown (n = 8 gastruloids). d, Expression of ligands of the 
BMP (top) and WNT (bottom) signalling pathways. Red box indicates genes with particularly 
strong AP localisation bias, n = 2 gastruloids. e, Maximum projection confocal images of 
human gastruloids at 72h made from the SMAD1-RFP;H2B-mCitrine cell line. Three 
representative examples are shown. Inset, close-up of region shown in red dashed-line 
bounded boxes. Scalebar; 40-50 µm (indicated on image). Representative examples of n = 
19 gastruloids, from N = 2 independent experiments. f, Processing to separate nuclear and 
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cytoplasmic component of SMAD1-RFP signal (left; see Methods for details) and resultant 
quantification of normalised nuclear : cytoplasmic ratio of SMAD1-RFP along the AP axis 
(right; each point represents a cell). Three representative examples are shown. 
Representative examples from N = 2 independent experiments. Scale bar as in panel e. g, 
Immunostaining of LEF1 and BRA expression in 96h RUES2-GLR human gastruloids. LEF1 
is localised in a gradient primarily in the posterior portion of the gastruloids. Scalebar; 100 µm. 
Shown are two representative examples, of n = 10 gastruloids, from N = 3 independent 
experiments. h, Immunostaining of WNT3A and BRA expression in 72h RUES2-GLR human 
gastruloids, showing close-up of posterior end. Scalebar; 50 µm. Max Proj; Maximum 
Projection. Shown is one representative example from n = 8 gastruloids, N = 2 independent 
experiments. i, Localised expression of Nodal signalling-related genes towards the posterior 
of Chiron pre-treated human gastruloids by tomo-sequencing, n = 2 gastruloids. 
 
Extended Data Fig. 7 | Perturbation of Nodal signaling in human gastruloids. a, 
Schematic representation of the protocol used to generate Chiron (Chi) and SB431542 (SB43) 
pre-treated human gastruloids (Chi + SB43). See Methods for details. b, Representative 
examples of the dynamic development of Chi + SB43 pre-treated gastruloids, from RUES2-
GLR cells (N = 3 experiments). Colours indicate reporter fluorescence as indicated in Fig. 2a. 
Scale bar, 100 µm. c, In situ hybridisation against BRA and SOX2 mRNA in 96h Chi + SB43 
gastruloids. Four representative examples are shown for each gene. d, Widefield imaging of 
the two 120h RUES2-GLR derived Chi + SB43 pre-treated human gastruloids used for tomo-
sequencing. Scale bars; 100 µm. mCer, mCerulean; tdTom, tdTomato; mCit, mCitrine. e, Venn 
diagram showing number of reproducibly-localised genes in the Chiron pre-treated human 
gastruloids (Chi hGld; green) and in the Chiron and SB43 pre-treated human gastruloids (Chi 
+ SB43 hGld; yellow). Numbers indicate counts of genes and percentage values in brackets 
indicate proportion of the full figure. See Source Data. f, Differentially expressed genes 
between Chi and Chi + SB43 pre-treated gastruloids (total expression). See Source Data and 
Supplementary Data 6 and Methods. g, Gene expression patterns detected in an averaged 
Chi pre-treated and averaged Chi + SB43 pre-treated gastruloid. Grey/Black panels show the 
hierarchical clustering of gene expression; Blue/Red bands indicate selective reproducibility 
between replicates from one or other pre-treatment conditions (Red, Chi + SB43 only; Blue, 
Chi only; Grey; both); Dark red box, cluster for which expression is lost following SB43 pre-
treatment (Cluster 4); White rows, lack of expression detected. See Methods for details. See 
Source Data and Supplementary Data 4. a-g, n = 2 Chi and 2 Chi + SB43 gastruloids. 
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Extended Data Fig. 8 | Transcriptional profiles of gastruloids exposed to Nodal 
inhibition before aggregation. a, Quantification of number of genes (left) and number of 
unique transcripts (right) detectable in each section along the anterior-posterior (AP) axis of 
Chiron + SB43 pre-treated human gastruloids made from 120 h RUES2-GLR gastruloids. Blue 
bars, sections above the threshold used for downstream tomo-seq analysis; Grey bars, 
sections below the threshold (see Methods for details). Two replicates are shown. b, 
Significantly reproducible gene expression patterns of individual replicates of Chiron + SB43 
pre-treated human gastruloids (left), and resultant average gastruloid (right) along the AP axis. 
See Source Data and Supplementary Data 4. c, Average expression pattern of genes from 
each cluster shown in panel (b). Ribbon indicates standard deviation for the set of genes within 
each cluster, line to the mean average. d, Expression detected for markers of all three germ 
layers. White rows indicate lack of expression detected for that gene. See Source Data and 
Supplementary Data 7. e, Gene expression traces along the AP axis of the four human 
gastruloids (gray lines, Chiron pre-treatment; blue lines, Chi + SB43 pre-treatment; solid lines, 
Replicate 1; dashed lines, Replicate 2). a-e, n = 2 gastruloids. 
 
Extended Data Fig. 9 | Unique transcriptional profiles of mouse and human gastruloids. 
a, Venn diagram showing number of common reproducibly localised genes in the Chiron pre-
treated human gastruloids (Chi hGld; green), the Chiron and SB43 pre-treated human 
gastruloids (Chi + SB43 hGld; yellow) and the mouse gastruloids (mGld; blue). Numbers 
indicate counts of genes and percentage values in brackets indicate proportion of the full 
figure. b, Unique reproducibly-localised gene expression in mouse gastruloids, not detected 
in Chiron pre-treated human gastruloids. c, Unique reproducibly localised gene expression in 
Chiron pre-treated human gastruloids, not detected in mouse gastruloids. d, Genes 
reproducibly localised in mouse gastruloids and expressed, but not reproducibly localized, in 
Chiron pre-treated human gastruloids. e, Genes reproducibly-localised in Chiron pre-treated 
human gastruloids and expressed, but not reproducibly localized, in mouse gastruloids. See 
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